Historical record - last NADAC effective date: 5/17/2017
This NDC is on FDA's drug shortage list (posted Sep 5, 2018)
Reported reason: Other
Product Information
LORAZEPAM 20 MG/10 ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.6796 per ML under NDC 00641604610. Its NADAC has been published 153 times since Jan 22, 2014.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
2 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641604610
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
5/17/2017
Active Ingredients
LORAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA018140FDA Approved
Before 1982
TE Code
AP
On Market Since
7/25/1980
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 20 MG/10 ML VIAL has been published 153 times since Jan 22, 2014, and over the history we have for it it has declined 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6796 per ML |
|---|---|
| All-time high | $0.7543 (Nov 12, 2014) |
| All-time low | $0.5700 (Nov 19, 2014) |
| Median price | $0.6796 |
| Average price | $0.6598 |
| Largest weekly change | -24.4% (Nov 19, 2014) |
| Weeks tracked | 153 |
| Tracking since | Jan 22, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-9.9%
Last surveyed May 16, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LORAZEPAM 20 MG/10 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 20 MG/10 ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $0.6796 per ML (NDC 00641604610), effective May 16, 2018.
How has the price of LORAZEPAM 20 MG/10 ML VIAL changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 20 MG/10 ML VIAL has declined 9.9%. It has been tracked across 153 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 20 MG/10 ML VIAL?
Since Jan 22, 2014, the NADAC for LORAZEPAM 20 MG/10 ML VIAL has ranged from a low of $0.5700 (Nov 19, 2014) to a high of $0.7543 (Nov 12, 2014), with a median of $0.6796 per ML.
Are there cheaper alternatives to LORAZEPAM 20 MG/10 ML VIAL?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LORAZEPAM 20 MG/10 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures LORAZEPAM 20 MG/10 ML VIAL?
LORAZEPAM 20 MG/10 ML VIAL (NDC 00641604610) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is LORAZEPAM 20 MG/10 ML VIAL in shortage?
Yes — NDC 00641604610 is currently listed in FDA's drug shortage database (posted Sep 5, 2018). Reported reason: Other.